Onartuzumab Antibody
Onartuzumab (MetMAb) is a humanized monovalent antibody targeting the c-MET receptor tyrosine kinase. It inhibits tumor growth by blocking HGF binding, receptor phosphorylation, and downstream signaling, as demonstrated in various in vitro and in vivo cancer models.
Product Specifications
Product Name Alternative
HGFR, MetMAb, cMet/HGFR, c-Met, cMet, RG-3638, PRO-14396
Target
C-Met/HGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
2.43 mg/mL
Purity
97.30% (May vary between batches)
Molecular Weight
146.99 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
047844 100 µg
PDCD1/PD-1/CD279 (pembrolizumab) discontinued, see 587286
Sign In for Pricing
View Details 
CAU26185-01 100 µL
Agouti Related Protein (AGRP) Polyclonal Antibody
Sign In for Pricing
View Details CAU26185-02 200 µL
Agouti Related Protein (AGRP) Polyclonal Antibody
Sign In for Pricing
View Details